Insider filing · JAZZ
Mark Douglas Smith
Director
profile →
Jazz Pharmaceuticals plc
JAZZ · Healthcare · 46 filings in 24 months
ticker →
Mark Douglas Smith sold $267K of Jazz Pharmaceuticals (JAZZ)
Executed Jun 15, disclosed Jun 17, 2 days later.
Value, as filed
$267K
1,157 sh × $230.55
Executed
Jun 15
the trade date, as filed
Disclosed
Jun 17
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MSMark Douglas Smith (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Jazz Pharmaceuticals plc (JAZZ). The largest single filing was $267K of JAZZ (1,157 sh × $230.55, as filed), executed Jun 15.
The name
JAZZHealthcare · Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→